Israel
· Delayed Price · Currency is ILS · Price in ILAEpitomee Medical Statistics
Total Valuation
Epitomee Medical has a market cap or net worth of ILS 91.33 million. The enterprise value is -2.49 million.
| Market Cap | 91.33M |
| Enterprise Value | -2.49M |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Epitomee Medical has 29.53 million shares outstanding. The number of shares has increased by 0.73% in one year.
| Shares Outstanding | 29.53M |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 38.00% |
| Owned by Institutions (%) | 20.50% |
| Float | 10.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.44 |
| PB Ratio | 0.82 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.11 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.06 |
Financial Position
The company has a current ratio of 15.87, with a Debt / Equity ratio of 14.17.
| Current Ratio | 15.87 |
| Quick Ratio | 15.75 |
| Debt / Equity | 14.17 |
| Debt / EBITDA | 3.42 |
| Debt / FCF | -0.39 |
| Interest Coverage | 730.02 |
Financial Efficiency
Return on equity (ROE) is -18.64% and return on invested capital (ROIC) is 1.25%.
| Return on Equity (ROE) | -18.64% |
| Return on Assets (ROA) | 1.07% |
| Return on Capital (ROIC) | 1.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 42 |
| Asset Turnover | 0.23 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.63% in the last 52 weeks. The beta is -0.36, so Epitomee Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.36 |
| 52-Week Price Change | -79.63% |
| 50-Day Moving Average | 314.31 |
| 200-Day Moving Average | 4,059.16 |
| Relative Strength Index (RSI) | 47.90 |
| Average Volume (20 Days) | 24,344 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Epitomee Medical had revenue of ILS 37.65 million and -22.72 million in losses. Loss per share was -0.76.
| Revenue | 37.65M |
| Gross Profit | 37.65M |
| Operating Income | 2.75M |
| Pretax Income | -22.72M |
| Net Income | -22.72M |
| EBITDA | 3.05M |
| EBIT | 2.75M |
| Loss Per Share | -0.76 |
Balance Sheet
The company has 109.72 million in cash and 15.90 million in debt, giving a net cash position of 93.82 million or 3.18 per share.
| Cash & Cash Equivalents | 109.72M |
| Total Debt | 15.90M |
| Net Cash | 93.82M |
| Net Cash Per Share | 3.18 |
| Equity (Book Value) | 112.16M |
| Book Value Per Share | 3.77 |
| Working Capital | 104.24M |
Cash Flow
In the last 12 months, operating cash flow was -28.63 million and capital expenditures -12.54 million, giving a free cash flow of -41.17 million.
| Operating Cash Flow | -28.63M |
| Capital Expenditures | -12.54M |
| Free Cash Flow | -41.17M |
| FCF Per Share | -1.39 |
Margins
Gross margin is 100.00%, with operating and profit margins of 7.30% and -60.35%.
| Gross Margin | 100.00% |
| Operating Margin | 7.30% |
| Pretax Margin | -60.35% |
| Profit Margin | -60.35% |
| EBITDA Margin | 8.10% |
| EBIT Margin | 7.30% |
| FCF Margin | -109.35% |
Dividends & Yields
Epitomee Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.73% |
| Shareholder Yield | -0.73% |
| Earnings Yield | -24.70% |
| FCF Yield | -45.08% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |